Dow Tumbles Over 400 Points; Bristol Myers Reports Strong Q4 Results

Company Performance - Bristol Myers Squibb & Co. reported fourth-quarter 2025 revenues of $12.50 billion, exceeding the consensus estimate of $12.281 billion, representing a 1% year-over-year increase [2] - The company reported adjusted earnings of $1.26, surpassing the consensus of $1.11, although this reflects a 25% decline due to the impacts of acquired IPRD charges and licensing income [2] Market Trends - U.S. stocks experienced a decline, with the Dow Jones index falling more than 400 points, down 0.86% to 49,073.13, while the NASDAQ dipped 1.03% to 22,669.07, and the S&P 500 dropped 0.91% to 6,820.34 [1] - In commodity markets, oil prices decreased by 2.5% to $63.51, gold fell by 0.9% to $4,907.60, silver dropped 9.4% to $76.455, and copper declined 0.5% to $5.8210 [3]